Bowman and Brooke Logo


October 5, 2016

Part Three of Berkley Life Sciences 3D Printed Drug and Device Article Series

Related Topics
news icon

In the final installment of the Berkley Life Sciences and Bowman and Brooke co-authored series, "Assessing, Managing and Insuring Against Risk in the Next Era of Drugs and Medical Devices—Part 3," authors Lindsey Adams-Hess along with Sonia Weiss and Cindy Khin delve into the insurance considerations for mitigating risk in this uncertain regulatory and legal landscape concerning 3D printed pharmaceuticals and medical devices.

Click the following links to read Part 1 and Part 2 in the 3D printing series. For more insights on the subject of product liability and 3D Printing in the life sciences industry, view our recent article "Law and Regulation of 3-D Printed Medical Devices" by Kim Schmid and Lindsey Adams-Hess.